Chicago, IL, United States of America

Kevin J Forney


Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 91(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kevin J Forney: Innovator in Agglutination Reaction Devices

Introduction

Kevin J Forney is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of agglutination immunoassays, holding a total of 2 patents. His work focuses on improving the efficiency and effectiveness of devices used in these reactions.

Latest Patents

Forney's latest patents include innovative designs for agglutination reaction devices. One of his patents, titled "Agglutination reaction device having geometrically modified chambers," describes a device that features a first hydrophilic layer, a second liquid-occlusive layer, and a third layer with a transparent opening for observing particles. This design allows for a non-random pattern of aggregated particles, enhancing the visibility of results. Another patent, "Agglutination reaction device utilizing selectively impregnated porous," introduces a layer of liquid absorbent material that controls the overall rate of liquid flow through the chamber, further optimizing the agglutination process.

Career Highlights

Kevin J Forney is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to develop and refine technologies that are crucial for immunoassay reactions. His contributions have been instrumental in advancing the capabilities of diagnostic devices.

Collaborations

Forney has collaborated with notable colleagues, including Robert G Parsons and Paul J Ropella. These partnerships have fostered innovation and have been vital in the development of his patented technologies.

Conclusion

Kevin J Forney's work in the field of agglutination reaction devices showcases his commitment to innovation and improvement in diagnostic technologies. His patents reflect a deep understanding of the complexities involved in immunoassays, making significant strides in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…